All In Biotech

Drug Trial Radar · NCT02382276

A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence

Last checked: Nov 20, 2026Latest source record: Jul 20, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

405

Actual

Start

Jul 13, 2015

Primary completion

Jan 18, 2017

Study completion Jan 18, 2017

Sponsor

Sponsor type
Industry
Collaborators
H. Lundbeck A/S
First posted
Mar 6, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The long-term safety and efficacy of nalmefene hydrochloride at 20 mg in patients with alcohol dependence will be evaluated in a multicenter, open-label, uncontrolled trial.

Conditions

  • Alcohol Dependence

Interventions

  • Nalmefene hydrochlorideDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Adverse EventsTime frame: 24-week treatment period

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Chubu

    Region, Japan

  • Hokkaido

    Region, Japan

  • Kanto

    Region, Japan

  • Kinki

    Region, Japan

  • Kyusyu

    Region, Japan

  • Tohoku

    Region, Japan

  • Tyugoku

    Region, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.